Benchmark analyst分析师Bruce Jackson对Mana Capital Acquisition Corp(MAAQ)进行了关注，给予其买入评级，目标价为14美元。Mana Capital Acquisition是一家特殊目的收购公司，正在收购私人持有的Cardio Diagnostics。交易完成后，Mana将更名为Cardio Diagnostics，并预计将以新的代码“CDIO”继续在纳斯达克全球市场上市。分析师表示，Cardio Diagnostics公司的Epi+Gen冠心病检测可以比目前可用的风险评估方法更好地评估患有3年冠心病风险的检测，Jackson估计公司2025年的收入为6200万美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.